Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
Erowid References Database
Krupitsky E, Nunes EV, Ling W, Illeperuma A, Gastfriend DR, Silverman BL. 
“Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial”. 
Lancet. 2011 Apr 02;377(9776):1506-13.
Abstract
Opioid dependence is associated with low rates of treatment-seeking, poor adherence to treatment, frequent relapse, and major societal consequences. We aimed to assess the efficacy, safety, and patient-reported outcomes of an injectable, once monthly extended-release formulation of the opioid antagonist naltrexone (XR-NTX) for treatment of patients with opioid dependence after detoxification.
Comments and Responses to this Article
#
Submit Comment
[ Cite HTML ]